Clinical Trial Update: CXCL9 and EASIX for Prediction of Acute Graft Versus Host Disease

View source ↗

Summary

This ClinicalTrials.gov entry describes a study evaluating CXCL9 and EASIX as predictors for acute graft-versus-host disease, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Snippet

Sponsor: Henry Ford Health System | Conditions: GVHD,Acute | Status: RECRUITING